{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:03:30Z","timestamp":1771545810963,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41390-025-04074-1","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:42:58Z","timestamp":1747258978000},"page":"339-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anlotinib mediates intrinsic drug resistance in hepatoblastoma through the GAD1\/GABA pathway"],"prefix":"10.1038","volume":"99","author":[{"given":"Haijin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linshan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4139-7912","authenticated-orcid":false,"given":"Haijin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"4074_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880-019-0411-7","volume":"39","author":"J Feng","year":"2019","unstructured":"Feng, J. et al. Hoffmann, Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun. 39, 62 (2019).","journal-title":"Cancer Commun."},{"key":"4074_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/CBM-200052","volume":"31","author":"M Ye","year":"2021","unstructured":"Ye, M. et al. USP7 promotes hepatoblastoma progression through activation of PI3K\/AKT signaling pathway. Cancer Biomark. 31, 107\u2013117 (2021).","journal-title":"Cancer Biomark."},{"key":"4074_CR3","doi-asserted-by":"publisher","first-page":"690641","DOI":"10.3389\/fonc.2021.690641","volume":"11","author":"H Chen","year":"2021","unstructured":"Chen, H., Guan, Q., Guo, H., Miao, L. & Zhuo, Z. The genetic changes of hepatoblastoma. Front. Oncol. 11, 690641 (2021).","journal-title":"Front. Oncol."},{"key":"4074_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros, J. et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 14, 834\u2013842 (2013).","journal-title":"Lancet Oncol."},{"key":"4074_CR5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s11912-022-01230-2","volume":"24","author":"PV Wu","year":"2022","unstructured":"Wu, P. V. & Rangaswami, A. Current approaches in hepatoblastoma-new biological insights to inform therapy. Curr. Oncol. Rep. 24, 1209\u20131218 (2022).","journal-title":"Curr. Oncol. Rep."},{"key":"4074_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0040-1722645","volume":"41","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Molecular mechanisms of hepatoblastoma. Semin. Liver Dis. 41, 28\u201341 (2021).","journal-title":"Semin. Liver Dis."},{"key":"4074_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3892\/ol.2020.11685","volume":"20","author":"Y Gao","year":"2020","unstructured":"Gao, Y., Liu, P. & Shi, R. Anlotinib as a molecular targeted therapy for tumors. Oncol. Lett. 20, 1001\u20131014 (2020).","journal-title":"Oncol. Lett."},{"key":"4074_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00383-021-05043-5","volume":"38","author":"D Yang","year":"2022","unstructured":"Yang, D. et al. Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib. Pediatr. Surg. Int. 38, 465\u2013472 (2022).","journal-title":"Pediatr. Surg. Int."},{"key":"4074_CR9","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-18-3995","volume":"79","author":"PD Vermeer","year":"2019","unstructured":"Vermeer, P. D. Exosomal induction of tumor innervation. Cancer Res. 79, 3529\u20133535 (2019).","journal-title":"Cancer Res."},{"key":"4074_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-019-1219-y","volume":"569","author":"P Mauffrey","year":"2019","unstructured":"Mauffrey, P. et al. Progenitors from the central nervous system drive neurogenesis in cancer. Nature 569, 672\u2013678 (2019).","journal-title":"Nature"},{"key":"4074_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41568-019-0159-z","volume":"19","author":"A Dart","year":"2019","unstructured":"Dart, A. Nervous tumours. Nat. Rev. Cancer 19, 366 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"4074_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","volume":"5","author":"RD Cervantes-Villagrana","year":"2020","unstructured":"Cervantes-Villagrana, R. D., Albores-Garc\u00eda, D., Cervantes-Villagrana, A. R. & Garc\u00eda-Acevez, S. J. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal. Transduct. Target. Ther. 5, 99 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"4074_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly, B., Faulkner, S., Jobling, P. & Hondermarck, H. Nerve dependence: from regeneration to cancer. Cancer Cell. 31, 342\u2013354 (2017).","journal-title":"Cancer Cell."},{"key":"4074_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0021-9258(19)50929-2","volume":"187","author":"E Roberts","year":"1950","unstructured":"Roberts, E. & Frankel, S. Gamma-aminobutyric acid in brain: its formation from glutamic acid. J. Biol. Chem. 187, 55\u201363 (1950).","journal-title":"J. Biol. Chem."},{"key":"4074_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22140","volume":"85","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Everolimus inhibits hepatoblastoma by inducing autophagy-dependent ferroptosis. Drug Dev. Res. 85, e22140 (2024).","journal-title":"Drug Dev. Res."},{"key":"4074_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-018-0664-7","volume":"11","author":"G Shen","year":"2018","unstructured":"Shen, G. et al. Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development. J. Hematol. Oncol. 11, 120 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"4074_CR17","doi-asserted-by":"publisher","first-page":"664853","DOI":"10.3389\/fonc.2021.664853","volume":"11","author":"S Li","year":"2021","unstructured":"Li, S. Anlotinib: a novel targeted drug for bone and soft tissue sarcoma. Front. Oncol. 11, 664853 (2021).","journal-title":"Front. Oncol."},{"key":"4074_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nature03875","volume":"436","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. & Tessier-Lavigne, M. Common mechanisms of nerve and blood vessel wiring. Nature 436, 193\u2013200 (2005).","journal-title":"Nature"},{"key":"4074_CR19","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.3390\/molecules24152678","volume":"24","author":"D-H Ngo","year":"2019","unstructured":"Ngo, D.-H. & Vo, T. S. An updated review on pharmaceutical properties of gamma-aminobutyric acid. Molecules 24, 2678 (2019).","journal-title":"Molecules"},{"key":"4074_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1023\/A:1007062802164","volume":"207","author":"GY Minuk","year":"2000","unstructured":"Minuk, G. Y. GABA and hepatocellular carcinoma. Mol. Cell. Biochem. 207, 105\u2013108 (2000).","journal-title":"Mol. Cell. Biochem."},{"key":"4074_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang, D. et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat. Cell. Biol. 24, 230\u2013241 (2022).","journal-title":"Nat. Cell. Biol."},{"key":"4074_CR22","doi-asserted-by":"publisher","first-page":"15801","DOI":"10.3390\/ijms242115801","volume":"24","author":"E Koz\u0142owska","year":"2023","unstructured":"Koz\u0142owska, E. & Swierniak, A. Mathematical model of intrinsic drug resistance in lung cancer. Int. J. Mol. Sci. 24, 15801 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"4074_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep30507","volume":"6","author":"BP Gronea","year":"2016","unstructured":"Gronea, B. P. & Maruska, K. P. Three distinct glutamate decarboxylase genes in vertebrates. Sci. Rep. 6, 30507 (2016).","journal-title":"Sci. Rep."},{"key":"4074_CR24","doi-asserted-by":"publisher","first-page":"G208","DOI":"10.1152\/ajpgi.00344.2016","volume":"312","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Protective roles of hepatic GABA signaling in acute liver injury of rats. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G208\u2013G218 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"4074_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada, D., Cheung, S. W., Finegold, M. J. & Knowles, B. B. Hep G2 is a hepatoblastoma-derived cell line. Hum. Pathol. 40, 1512\u20131515 (2009).","journal-title":"Hum. Pathol."},{"key":"4074_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2183\/pjab.94.026","volume":"94","author":"M Terunuma","year":"2018","unstructured":"Terunuma, M. Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci. 94, 390\u2013411 (2018).","journal-title":"Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04074-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:07:11Z","timestamp":1771542431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4074"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04074-1","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study does not involve human participants, and therefore, no patient consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}